Shawn Leland's most recent trade in Elevation Oncology Inc was a trade of 186,500 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 14, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Elevation Oncology Inc | Shawn Leland | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 186,500 | 186,500 | - | - | Employee Stock Option (Right to Buy) |